Recent investigations have shown that plasma EVs contain BDNF[181] and the level and biochemical properties of BDNF are potential biomarkers for conditions such as walking speed decline in older adults[182] and disturbance-related motor symptoms in patients with Parkinson’s disease[183]. This evidence concerns the gene BDNF and Parkinson disease.